World Library  
Flag as Inappropriate
Email this Article

Paul Terasaki

Article Id: WHEBN0015523862
Reproduction Date:

Title: Paul Terasaki  
Author: World Heritage Encyclopedia
Language: English
Subject: Gila River War Relocation Center, List of University of California, Los Angeles people, Hisako Terasaki
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Paul Terasaki

Paul I. Terasaki
Born (1929-09-10) September 10, 1929 (age 84)
Los Angeles, California
Alma mater UCLA
Known for organ transplant medicine; tissue typing
Notable awards UCLA Terasaki Life Sciences Building

Paul Ichiro Terasaki (born September 10, 1929) is a noted scientist in the field of human organ transplant technology and Professor Emeritus of Surgery at UCLA School of Medicine.

He spent three high school years during World War II interned with his family and other Japanese Americans in the Gila River War Relocation Center. Later he earned his doctorate in zoology at UCLA and was appointed to the medical school faculty.

In 1964, Terasaki developed the microcytotoxicity test, a tissue-typing test for organ transplant donors and recipients that required only 1 microliter each of antisera used to identify One Lambda, have played a central role in the development of tissue typing and transplantation surgery.

Terasaki established UCLA's HLA laboratory,[3] and also established the UCLA Kidney Transplant Registry, the largest in the world. In 1999, he retired from UCLA, but within a year resumed his academic pursuits with the creation of the Terasaki Foundation, a research center dedicated to cancer immunotherapy and the study of humoral immunity and transplantation.

On May 13, 2010, UCLA announced the naming of the new life science building for Terasaki, who has given $50 million to the Division of Life Sciences in the UCLA College of Letters and Science, which is the largest ever given to the UCLA College. The structure is known as the Terasaki Life Sciences Building.[4] He was awarded the 2011 UCLA Edward A. Dickson Alumnus of the Year award on April 13, 2012 and the UCLA medal on June 15, 2012.

Paul Terasaki is married to artist Hisako Terasaki; they have four children.

Publications

  • Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998–1000.
  • Terasaki PI. Resolution by HLA testing of 1000 paternity cases not excluded by ABO testing. J Family Law 1977; 16: 543–557.
  • Scholsstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HLA antigen, w27, with ankylosing spondylitis. N Engl J Med 1973; 228: 704–706.
  • Collins GM, Bravo-Shugarman M, Terasaki PI. Kidney preservation for transportation. Initial perfusion and 30 hour ice storage. Lancet 1969; ii: 1219.
  • Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years’ experience with national sharing of HLA matched cadaveric kidneys for transplantation. New Engl J Med 2000; 343: 1078–1084.
  • Terasaki PI, Marchioro TL, Starzl TE. Serotyping of human lymphocyte antigens. Preliminary trials on long-term kidney homograft survivors. Nat Acad Sci Monograph 1965; 83–96.
  • Terasaki PI, ed. History of HLA. Ten Recollections. Los Angeles: UCLA Tissue Typing Laboratory; 1990.
  • Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735–739.
  • Nishikawa K, Terasaki PI. Annual trends and triple therapy – 1991–2000. In: Cecka, JM, Terasaki, PI, eds. Clinical Transplants 2001. Los Angeles: UCLA Immunogenetics Center; 2002, pp. 247–270.
  • Terasaki PI. Red cell crossmatching for heart transplants (letter). N Engl J Med 1991; 325: 1748.
  • Mickey MR, Kreisler M, Albert ED, Tanaka N, Terasaki PI. Analysis of HLA incompatibility in human renal transplants. Tissue Antigens 1971; 2: 57–67.
  • Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333–336.
  • Terasaki PI, Mickey MR, Kreisler M. Presensitization and kidney transplant failures. Postgrad Med 1970; 47: 89–100.
  • Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 4: 253–259.
  • Terasaki PI, Cho YW, Cecka JM. Editorial: Strategy for eliminating the kidney shortage. In: Cecka, M, Terasaki, PI, eds. Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1998, pp. 265–267.
  • Mckenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69:319–326.
  • Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74: 1192–1194.
  • Terasaki PI. Antibody response to homografts. I. Preliminary studies of the time of appearance of lymphoagglutinins upon homografting. Am Surg 1959; 11: 896–899.
  • Terasaki PI. The humoral theory of transplantation. Am J Transpl 2003; 3: 665–673.
  • Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose heart has stopped beating. N Engl J Med 1998; 338: 221–225.

References

See also its links to oral history video clips.

  • Starzl TE. The Puzzle People – Memoirs of a Transplant Surgeon. Pittsburgh, PA: University of Pittsburgh Press; 1992.
  • Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333–1338.
  • El-Awar N, Terasaki P, Lazda V, Nikaein A, Manning C, Arnold AN. Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplant Proc 2002; 34:2531–2532.
  • Halloran PF. Call for revolution: a new approach to describing allograft deterioration. Am J Transpl 2002; 2: 195–200.

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.